Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ancuta Jurj

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
BMC Cancer|July 8, 2025
Extracellular Vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applicationsAncuta Jurj, Doru Paul, George A Calin
Cancer Drug Resistance (Alhambra, Calif.)|December 22, 2025
MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapyMichael Attathikhun, Ancuta Jurj, George A Calin
Medicina (Kaunas, Lithuania)|December 1, 2020
<i>TET2/IDH1/2/WT1</i> and <i>NPM1</i> Mutations Influence the <i>RUNX1</i> Expression Correlations in Acute Myeloid LeukemiaSergiu Pasca, Ancuta Jurj, Ciprian Tomuleasa, et al.
Cancers|April 3, 2021
The Potential Equivalents of <i>TET2</i> MutationsSergiu Pasca, Ancuta Jurj, Mihnea Zdrenghea, et al.
Trends in Cancer|August 6, 2024
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapyAncuta Jurj, Beatrice Fontana, Gabriele Varani, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 16, 2022
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Ancuta Jurj, Calin Ionescu, Ioana Berindan-Neagoe, et al.
Frontiers in Immunology|May 1, 2020
MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory DiseasesSergiu Pasca, Ancuta Jurj, Bobe Petrushev, et al.
Nature Reviews. Clinical Oncology|January 15, 2026
MicroRNAs in oncology: a translational perspective in the era of AIAncuta Jurj, Mihnea P Dragomir, Ziyi Li, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 4, 2019
Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironmentTiberiu Tat, Ancuta Jurj, Cristina Selicean, et al.
Critical Reviews in Immunology|April 6, 2021
Implications of TET2 in CAR-T Cell Activity and Target Response to CAR-T Cell Therapy: Lessons Learned from T CellsSergiu Pasca, Ancuta Jurj, Catalin Constantinescu, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
BMC Cancer|July 8, 2025
Extracellular Vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applicationsAncuta Jurj, Doru Paul, George A Calin
Cancer Drug Resistance (Alhambra, Calif.)|December 22, 2025
MicroRNAs as key regulators of cancer drug resistance: insights and future directions in chemotherapy, targeted-therapy, radiotherapy, and immunotherapyMichael Attathikhun, Ancuta Jurj, George A Calin
Medicina (Kaunas, Lithuania)|December 1, 2020
<i>TET2/IDH1/2/WT1</i> and <i>NPM1</i> Mutations Influence the <i>RUNX1</i> Expression Correlations in Acute Myeloid LeukemiaSergiu Pasca, Ancuta Jurj, Ciprian Tomuleasa, et al.
Cancers|April 3, 2021
The Potential Equivalents of <i>TET2</i> MutationsSergiu Pasca, Ancuta Jurj, Mihnea Zdrenghea, et al.
Trends in Cancer|August 6, 2024
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapyAncuta Jurj, Beatrice Fontana, Gabriele Varani, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 16, 2022
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?Ancuta Jurj, Calin Ionescu, Ioana Berindan-Neagoe, et al.
Frontiers in Immunology|May 1, 2020
MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory DiseasesSergiu Pasca, Ancuta Jurj, Bobe Petrushev, et al.
Nature Reviews. Clinical Oncology|January 15, 2026
MicroRNAs in oncology: a translational perspective in the era of AIAncuta Jurj, Mihnea P Dragomir, Ziyi Li, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 4, 2019
Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironmentTiberiu Tat, Ancuta Jurj, Cristina Selicean, et al.
Critical Reviews in Immunology|April 6, 2021
Implications of TET2 in CAR-T Cell Activity and Target Response to CAR-T Cell Therapy: Lessons Learned from T CellsSergiu Pasca, Ancuta Jurj, Catalin Constantinescu, et al.
Pageof 8